Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation

This study examines the impacts of the urokinase-type plasminogen activator (uPA) on the in vitro maturation (IVM) of bovine oocytes. Cumulus–oocyte complexes in IVM medium were treated with uPA, amiloride (an uPA inhibitor), dimethyl sulfoxide (DMSO) or left untreated (control group). After 24 h of IVM, oocytes were recovered for testing or were in vitro fertilized and cultured to the blastocyst stage. The factors examined in all groups were (i) oocyte nuclear maturation (Hoëscht staining); (ii) oocyte cytoplasmic maturation (cortical granules, CGs, distribution assessed by LCA-FITC); (iii) oocyte and cumulus cell (CC) gene expression (RT-qPCR); and (iv) embryo development (cleavage rate and blastocyst yield). Oocytes subjected to uPA treatment showed rates of nuclear maturation and CG distribution patterns similar to controls (P> 0.05), whereas lower rates of oocyte maturation were recorded in the amiloride group (P< 0.05). Both in oocytes and CC, treatment with uPA did not affect the transcription of genes related to apoptosis, cell junctions, cell cycle or serpin protease inhibitors. In contrast, amiloride altered the expression of genes associated with cell junctions, cell cycle, oxidative stress and CC serpins. No differences were observed between the control and uPA group in cleavage rate or in blastocyst yield recorded on Days 7, 8 or 9 post-insemination. However, amiloride led to drastically reduced cleavage rate (28.5% vs 83.2%) and Day 9 embryo production (6.0% vs 21.0%) over the rates recorded for DMSO. These results indicate that the proteolytic activity of uPA is needed for successful oocyte maturation in bovine. © 2017 Society for Reproduction and Fertility.

Saved in:
Bibliographic Details
Main Authors: Roldán-Olarte, M., Maillo, V., Sánchez-Calabuig, M. J., Beltrán-Breña, P., Rizos, D., Gutiérrez-Adán, A.
Format: journal article biblioteca
Language:eng
Published: 2017
Online Access:http://hdl.handle.net/20.500.12792/3878
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-inia-es-20.500.12792-3878
record_format koha
spelling dig-inia-es-20.500.12792-38782020-12-15T09:55:08Z Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation Roldán-Olarte, M. Maillo, V. Sánchez-Calabuig, M. J. Beltrán-Breña, P. Rizos, D. Gutiérrez-Adán, A. This study examines the impacts of the urokinase-type plasminogen activator (uPA) on the in vitro maturation (IVM) of bovine oocytes. Cumulus–oocyte complexes in IVM medium were treated with uPA, amiloride (an uPA inhibitor), dimethyl sulfoxide (DMSO) or left untreated (control group). After 24 h of IVM, oocytes were recovered for testing or were in vitro fertilized and cultured to the blastocyst stage. The factors examined in all groups were (i) oocyte nuclear maturation (Hoëscht staining); (ii) oocyte cytoplasmic maturation (cortical granules, CGs, distribution assessed by LCA-FITC); (iii) oocyte and cumulus cell (CC) gene expression (RT-qPCR); and (iv) embryo development (cleavage rate and blastocyst yield). Oocytes subjected to uPA treatment showed rates of nuclear maturation and CG distribution patterns similar to controls (P> 0.05), whereas lower rates of oocyte maturation were recorded in the amiloride group (P< 0.05). Both in oocytes and CC, treatment with uPA did not affect the transcription of genes related to apoptosis, cell junctions, cell cycle or serpin protease inhibitors. In contrast, amiloride altered the expression of genes associated with cell junctions, cell cycle, oxidative stress and CC serpins. No differences were observed between the control and uPA group in cleavage rate or in blastocyst yield recorded on Days 7, 8 or 9 post-insemination. However, amiloride led to drastically reduced cleavage rate (28.5% vs 83.2%) and Day 9 embryo production (6.0% vs 21.0%) over the rates recorded for DMSO. These results indicate that the proteolytic activity of uPA is needed for successful oocyte maturation in bovine. © 2017 Society for Reproduction and Fertility. 2020-10-22T15:40:02Z 2020-10-22T15:40:02Z 2017 journal article http://hdl.handle.net/20.500.12792/3878 10.1530/REP-17-0204 eng Attribution-NonCommercial-ShareAlike 4.0 International http://creativecommons.org/licenses/by-nc-sa/4.0/ open access
institution INIA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-inia-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del INIA España
language eng
description This study examines the impacts of the urokinase-type plasminogen activator (uPA) on the in vitro maturation (IVM) of bovine oocytes. Cumulus–oocyte complexes in IVM medium were treated with uPA, amiloride (an uPA inhibitor), dimethyl sulfoxide (DMSO) or left untreated (control group). After 24 h of IVM, oocytes were recovered for testing or were in vitro fertilized and cultured to the blastocyst stage. The factors examined in all groups were (i) oocyte nuclear maturation (Hoëscht staining); (ii) oocyte cytoplasmic maturation (cortical granules, CGs, distribution assessed by LCA-FITC); (iii) oocyte and cumulus cell (CC) gene expression (RT-qPCR); and (iv) embryo development (cleavage rate and blastocyst yield). Oocytes subjected to uPA treatment showed rates of nuclear maturation and CG distribution patterns similar to controls (P> 0.05), whereas lower rates of oocyte maturation were recorded in the amiloride group (P< 0.05). Both in oocytes and CC, treatment with uPA did not affect the transcription of genes related to apoptosis, cell junctions, cell cycle or serpin protease inhibitors. In contrast, amiloride altered the expression of genes associated with cell junctions, cell cycle, oxidative stress and CC serpins. No differences were observed between the control and uPA group in cleavage rate or in blastocyst yield recorded on Days 7, 8 or 9 post-insemination. However, amiloride led to drastically reduced cleavage rate (28.5% vs 83.2%) and Day 9 embryo production (6.0% vs 21.0%) over the rates recorded for DMSO. These results indicate that the proteolytic activity of uPA is needed for successful oocyte maturation in bovine. © 2017 Society for Reproduction and Fertility.
format journal article
author Roldán-Olarte, M.
Maillo, V.
Sánchez-Calabuig, M. J.
Beltrán-Breña, P.
Rizos, D.
Gutiérrez-Adán, A.
spellingShingle Roldán-Olarte, M.
Maillo, V.
Sánchez-Calabuig, M. J.
Beltrán-Breña, P.
Rizos, D.
Gutiérrez-Adán, A.
Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
author_facet Roldán-Olarte, M.
Maillo, V.
Sánchez-Calabuig, M. J.
Beltrán-Breña, P.
Rizos, D.
Gutiérrez-Adán, A.
author_sort Roldán-Olarte, M.
title Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
title_short Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
title_full Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
title_fullStr Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
title_full_unstemmed Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
title_sort effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation
publishDate 2017
url http://hdl.handle.net/20.500.12792/3878
work_keys_str_mv AT roldanolartem effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
AT maillov effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
AT sanchezcalabuigmj effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
AT beltranbrenap effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
AT rizosd effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
AT gutierrezadana effectofurokinasetypeplasminogenactivatoroninvitrobovineoocytematuration
_version_ 1758004697080266752